nmCRPC made easy!! Who, when and how
An episode of the GU Cast | Urology Podcast podcast, hosted by Professor Declan Murphy & Dr Renu Eapen, titled "nmCRPC made easy!! Who, when and how" was published on November 18, 2023 and runs 37 minutes.
November 18, 2023 ·37m · GU Cast | Urology Podcast
Summary
Prof Fred Saad (University of Montreal) drops in to chat about the interesting condition that is non-metastatic castration-resistant prostate cancer (nmCRPC). Which men are at risk of developing metastases? When should we use an AR pathway inhibitor? Why PSMA PET/CT should NOT be used. And hear his thoughts on "dabbling" in prostate cancer! Also joined by Professor Shankar Siva and Dr Louise Kostos from Peter MacCallum Cancer Centre. Hosted as ever by Dr Renu Eapen and Professor Declan Murph...
Episode Description
Prof Fred Saad (University of Montreal) drops in to chat about the interesting condition that is non-metastatic castration-resistant prostate cancer (nmCRPC). Which men are at risk of developing metastases? When should we use an AR pathway inhibitor? Why PSMA PET/CT should NOT be used. And hear his thoughts on "dabbling" in prostate cancer!
Also joined by Professor Shankar Siva and Dr Louise Kostos from Peter MacCallum Cancer Centre. Hosted as ever by Dr Renu Eapen and Professor Declan Murphy.
Fred was on a speaker tour in Australia supported by Bayer Pharmaceuticals and this Themed Podcast is supported by Bayer, Silver Partners of GU Cast.
Update - we mentioned that darolutamide was the only ARPI listed for reimbursement in Australia (true at time of recording). We can update that all TGA approved ARPIs for nmCRPC are now reimbursed in Australia.
Even better on our YouTube channel
Similar Episodes
Aug 20, 2020 ·7m
Apr 7, 2020 ·7m
Apr 3, 2020 ·7m
Oct 29, 2019 ·8m
Jul 20, 2018 ·24m
Jul 20, 2018 ·12m